Moleculin Biotech, Inc. (LON:0K2H)

Moleculin Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.7	4.28	23.55	43.15	70.9	15.17
Cash & Short-Term Investments	6.7	4.28	23.55	43.15	70.9	15.17
Cash Growth	-28.73%	-81.83%	-45.42%	-39.15%	367.30%	41.34%
Other Current Assets	1.18	0.92	2.72	2.45	1.59	2.03
Total Current Assets	7.89	5.19	26.27	45.6	72.5	17.2
Net Property, Plant & Equipment	0.42	0.58	0.8	0.68	0.45	0.69
Other Intangible Assets	11.15	11.15	11.15	11.15	11.15	11.15
Other Long-Term Assets	0.9	-	-	-	-	-
Total Assets	20.35	16.93	38.22	57.42	84.09	29.03
Accounts Payable	2.12	2.03	2.5	2.1	1.36	1.13
Accrued Expenses	3.57	3.33	4.32	2.72	2.26	1.79
Total Current Liabilities	5.68	5.36	6.82	4.82	3.62	2.92
Long-Term Leases	0.26	0.36	0.47	0.34	0.06	0.16
Other Long-Term Liabilities	41.33	-	4.86	0.08	1.41	8.19
Total Long-Term Liabilities	41.59	0.36	5.33	0.41	1.48	8.35
Total Liabilities	47.27	5.72	12.14	5.23	5.1	11.27
Common Stock	0.05	0	0.03	0.03	0.03	0.07
Additional Paid-in Capital	194.63	183.69	157.65	153.99	151.73	74.54
Accumulated Other Comprehensive Income	-0.04	-0.04	-0.01	0.01	0.04	0.07
Retained Earnings	-221.56	-172.44	-131.6	-101.84	-72.81	-56.92
Shareholders' Equity	-26.92	11.21	26.07	52.19	78.99	17.76
Total Liabilities & Equity	20.35	16.93	38.22	57.42	84.09	29.03
Total Debt	0.26	0.36	0.47	0.34	0.06	0.16
Net Cash (Debt)	6.45	3.92	23.08	42.81	70.84	15.01
Net Cash Growth	64.41%	-83.01%	-46.10%	-39.57%	371.83%	43.55%
Net Cash Per Share	9.59	28.46	292.01	561.23	988.43	571.85
Book Value	-26.92	11.21	26.07	52.19	78.99	17.76
Book Value Per Share	-40.05	81.38	329.94	684.22	1102.19	676.44
Tangible Book Value	-38.07	0.06	14.93	41.04	67.85	6.61
Tangible Book Value Per Share	-56.64	0.44	188.87	538.07	946.64	251.84

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.